Skip to content
Home/Companies/Biotech/MinervaX
MinervaX

MinervaX

Biotech·Denmark·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns MinervaX?

MinervaX is currently owned by Trill Impact through Trill Impact Ventures (2021 vintage), since 2022. Across its history, MinervaX has been through 6 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-08-10

Trill Impact
Most recent investor
Trill Impact
Trill Impact Ventures · 2021 · VC
6 ownership periods · full history below

Key facts

HQDenmark
SectorBiotech
StatusActive
Websiteminervax.com
Key takeaways
  • ·Co-held by PreSeed Ventures, Novo Holdings, Sunstone Life Science Ventures, Industrifonden, Wellington Partners and Trill Impact since 2010.
  • ·6 distinct PE sponsors across ownership cycles.

Ownership history

6 ownership periods · co-invest detected

Active
Co-held by PreSeed Ventures, Novo Holdings, Sunstone Life Science Ventures, Industrifonden, Wellington Partners and Trill Impact since 2010.
Co-invest · 6 holders · 2010 · present
PreSeed Ventures
PreSeed VenturesActive
2010 · present(16yr) · PreSeed Ventures (early) · 2000 · VC
Sunstone Life Science Ventures
Sunstone Life Science VenturesActive
2014 · present(12yr) · Sunstone Life Science Ventures III · 2007 · VC
Novo Holdings
Novo HoldingsActive
2014 · present(12yr) · Novo Holdings Venture Investments · 1999 · VC
Wellington Partners
Wellington PartnersActive
2020 · present(6yr) · Wellington Partners Life Sciences · 1998 · VC
Industrifonden
IndustrifondenActive
2020 · present(6yr) · Industrifonden Evergreen · 1991 · VC
Trill Impact
Trill ImpactActive
2022 · present(4yr) · Trill Impact Ventures · 2021 · VC

More from Trill Impact Ventures

Other portfolio companies in the same fund.

Rail-Flow
Active
LogisticsGermany· 2025
May Health
May Health
Active
MedTechFrance· 2024
Soil Capital
Active
AgTechBelgium· 2024
Open Cosmos
Open Cosmos
Active
Deep TechUK· 2023
tado
tado
Active
ClimateTechGermany· 2023
Cinclus Pharma
Cinclus Pharma
Exited 2024
PharmaSweden· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track MinervaX

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy MinervaX?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on MinervaX.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue